Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | COMT | P21964 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27831848 | 0.76 | RAB9A (0.38) | CYP1A2LRRK2ALDH1A1KDM4ENPC1 | |
| SCHEMBL29343719 | 0.72 | — | — | |
| SCHEMBL24977207 | 0.72 | — | — | |
| SCHEMBL24828585 | 0.71 | — | — | |
| SCHEMBL24013869 | 0.71 | — | — | |
| SCHEMBL18390051 | 0.71 | HTT (0.38) | ALDH1A1KDM4ENPC1LMNAHTT | |
| Ammonia Solution, Strong SCHEMBL28919773 | 0.69 | HTT (0.37) | ALDH1A1KDM4ENPC1LMNAHTT | |
| SCHEMBL24937059 | 0.68 | SMN1; SMN2 (0.33) | ALDH1A1KDM4ENPC1HTTSMN1; SMN2 | |
| SCHEMBL21721470 | 0.68 | HTT (0.33) | ALDH1A1KDM4ENPC1HTTSMN1; SMN2 | |
| SCHEMBL26388989 | 0.68 | HTT (0.33) | ALDH1A1KDM4ENPC1HTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4400497-A1 | 3CLPRO PROTEASE INHIBITOR | Shanghai Qilu Pharmaceutical Research and Development Centre Ltd. (CN) | 2024-07-17 | — | — | EP | disclosed |